Navigation Links
Scientists Unravel Link Between HRT And Breast Cancer Gene, BRCA1

It is a well established fact that any genetic alterations in either the BRCA1 or BRCA2 gene can predispose to breast cancer. The BRCA1 gene, has been known to play a significant role// in the utilization of estrogen in cells present in the breast. Researchers from Georgetown University Medical Center have now found that the BRCA1 gene also controls the activity of another important sex hormone, progesterone.

The results of the present study can be found in the latest issue of Molecular Endocrinology. This finding could eventually serve to explain the increased susceptibility of women with BRCA1 mutations to suffer form different forms of hormone dependent cancer, such as those of the cervix, endometrium and breast.

The researchers were interested in finding out how loss of BRCA1 activity could predispose to formation of hormone dependent tumors. Progesterone was taken up as the main target, as women who used hormone replacement therapy (HRT ) were found to have an increased cancer susceptibility than those on estrogen alone.

The utilization of progesterone is highly regulated. Furthermore, the activation occurs when there is a necessity for cell growth, such as during the menstrual cycle and during pregnancy. Specific receptor molecules, located inside the cell play a critical role in the binding and transport of progesterone. A gene expression is then manifested due to activation of the receptor.

In order to understand the role played by BRCA1 in signal transduction of the progesterone receptor, the researchers used breast cancer cell lines, sensitive to progesterone levels. These cell lines were genetically manipulated to either under express or over express the BRCA1 gene. Breast tissue, in which BRCA1 was partially deleted was also used for the study. The cell lines were treated with varying concentrations of estrogen, progesterone and estrogen-progesterone combination.

From the analysis of the results obtained, it was evident that BRCA1 gene interacted with the progesterone receptor (even in the absence of progesterone) to induce gene inactivation. This was in contrast to the growth stimulation of breast epithelial cells in mice (deficient in BRCA1) treated with the hormone combination.

The results of the present study have several valuable clinical implications. A majority of the breast tumors have deficient expression of the BRCA1 gene. Such patients could benefit by the administration of anti-estrogen therapy. The results of the present study further highlight that use of a specific anti-progesterone agent could maximize the clinical benefit.


'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: